Search

Your search keyword '"Reiffers, Josy"' showing total 28 results

Search Constraints

Start Over You searched for: Author "Reiffers, Josy" Remove constraint Author: "Reiffers, Josy" Database Academic Search Index Remove constraint Database: Academic Search Index
28 results on '"Reiffers, Josy"'

Search Results

1. The post-transplant cytogenetic response to interferon is a major determinant of survival after autologous stem cell transplantation for chronic myeloid leukaemia in chronic phase.

2. Abrogation of post-myeloablative chemotherapy neutropenia by ex-vivo expanded autologous CD34-positive cells.

Catalog

Books, media, physical & digital resources

3. CD95 triggers Orai1-mediated localized Ca2+ entry, regulates recruitment of protein kinase C (PKC) β2, and prevents death-inducing signaling complex formation.

4. α-defensin 1-3 and α-defensin 4 as predictive markers of imatinib resistance and relapse in CML patients.

5. Discontinuation of imatinib in patients with chronic myeloid leukaemia who have maintained complete molecular remission for at least 2 years: the prospective, multicentre Stop Imatinib (STIM) trial

6. Recombinant Differential Anchorage Probes that Tower over the Spatial Dimension of Intracellular Signals for High Content Screening and Analysis.

7. Triptolide cooperates with chemotherapy to induce apoptosis in acute myeloid leukemia cells

8. Large-scale expansion and transplantation of CD34+ hematopoietic cells: in vitro and in vivo confirmation of neutropenia abrogation related to the expansion process without impairment of the long-term engraftment capacity.

9. A clinical-scale expansion of mobilized CD34+ hematopoietic stem and progenitor cells by use of a new serum-free medium.

10. research paper Long-acting β2-adrenergic formoterol and salmeterol induce the apoptosis of B-chronic lymphocytic Leukaemia cells.

11. Flt3-ligand induces adhesion of haematopoietic progenitor cells via a very late antigen (VLA)-4- and VLA-5-dependent mechanism.

12. Severe Prolonged Red Blood Cell Aplasia and Thrombocytopenia Induced by Parvovirus B19 Infection in a Patient with Sarcoidosis.

13. Derivative (7)t(7;8)(q34;q21): a new additional cytogenetic abnormality in acute promyelocytic leukemia

14. A Randomized Prospective Multicentre Trial of Cefpirome Versus Piperacillin-Tazobactam in Febrile Neutropenia.

15. Second early allogeneic stem cell transplantations for graft failure in acute leukaemia, chronic myeloid leukaemia and aplastic anaemia.

16. No impact of high-dose cytarabine on the outcome of patients transplanted for acute myeloblastic leukaemia in first remission.

17. Severe pancytopenia triggered by recombinant hepatitis B vaccine.

18. Increased liposome‐mediated gene transfer into haematopoietic cells grown in adhesion to stromal or fibroblast cell line monolayers.

19. Genomic acute myeloid leukemia-associated inv(16)(p13q22) breakpoints are tightly clustered.

20. Expansion and differentiation of haemopoietic progenitor cells on endothelialized hydroxyapatite under static conditions.

21. Ex Vivo Cytokine Expansion of Peripheral Blood Ph-Negative Cells in Chronic Myeloid Leukaemia.

22. A Phase II Study of Interleukin-2 in 49 Patients with Relapsed or Refractory Acute Leukemia.

23. Total body irradiation–high-dose cytosine arabinoside and melphalan followed by allogeneic bone marrow transplantation from HLA-identical siblings in the treatment of children with acute lymphoblastic leukaemia after relapse while receiving ...

24. Bcr-abl translocation can occur during the induction of multidrug resistance and confers apoptosis resistance on myeloid leukemic cell lines.

25. Five-Year Follow-up of Patients Receiving Imatinib for Chronic Myeloid Leukemia.

26. Imatinib Compared with Interferon and Low-Dose Cytarabine for Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia.

27. Noninvasive Ventilation in Immunosuppressed Patients with Pulmonary Infiltrates, Fever, and Acute Respiratory Failure.

28. A Controlled Study of Recombinant Human Granulocyte Colony-Stimulating Factor in Elderly Patients after Treatment for Acute Myelogenous Leukemia.